Evidence-based therapy of chronic urticaria;Evidenzbasierte therapie der chronischen urtikaria

JDDG - Journal of the German Society of Dermatology

Volumn 5, Issue 2, 2007, Pages 146-157

  Wedi, Bettina ^a   Kapp, Alexander ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; AZELASTINE; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CETIRIZINE; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAPSONE; DESLORATADINE; DOXEPIN; EBASTINE; FEXOFENADINE; HYDROXYCHLOROQUINE; KETOTIFEN; LEVOCETIRIZINE; LORATADINE; METHOTREXATE; MIDAZOLAM; NIFEDIPINE; OXATOMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SALAZOSULFAPYRIDINE; STANOZOLOL; TERBUTALINE; THYROXINE; UNINDEXED DRUG; WARFARIN; ZAFIRLUKAST;

ANEMIA; ANGIONEUROTIC EDEMA; AUTOIMMUNE THYROIDITIS; BLEEDING; BLOOD VESSEL PERMEABILITY; BONE MARROW TOXICITY; BULLOUS PEMPHIGOID; CELL INFILTRATION; CHRONIC URTICARIA; CLINICAL TRIAL; CONSTIPATION; CROHN DISEASE; CYSTITIS; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM ULCER; DRUG HYPERSENSITIVITY; EMBASE; ERYTHEMA MULTIFORME; EVIDENCE BASED MEDICINE; FLU LIKE SYNDROME; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HYPERTENSION; IMMUNE DEFICIENCY; IMPOTENCE; KIDNEY FUNCTION; LEUKOPENIA; LIPID METABOLISM; LIVER FUNCTION; LIVER TOXICITY; LUNG FIBROSIS; MEDLINE; META ANALYSIS; NEPHROTOXICITY; OCCUPATIONAL DISEASE; PRACTICE GUIDELINE; PRURITUS; QUALITY OF LIFE; RETINOPATHY; REVIEW; RHEUMATOID ARTHRITIS; SCABIES; SEDATION; SIDE EFFECT; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS; STREPTOCOCCUS INFECTION; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; URTICARIA; VASCULITIS; WEIGHT GAIN; XEROSTOMIA; YERSINIA; YERSINIOSIS;

CHRONIC DISEASE; DERMATOLOGIC AGENTS; EVIDENCE-BASED MEDICINE; HISTAMINE H1 ANTAGONISTS; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME; URTICARIA;

EID: 33846828833     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2007.06074.x     Document Type: Review

References (9)

1. 2LEN/EDF guideline: definition, classification, and diagnosis of urticaria. Allergy, 2006; 61: 316-320.
2. Grattan CE. Autoimmune urticaria. Immunol Allergy Clin North Am 2004; 24(2): 163-81, v.
3. Wedi B, Raap U, Kapp A. Chronic urticaria and infections. Curr Opin Allergy Clin Immunol 2004; 4(5): 387-396.
4. Wedi B, Kapp A. Chronic urticaria: assessment of current treatment. Exp Rev Clin Immunol 2005; 1: 459-473.
5. 2LEN/EDF guideline: Management of urticaria. Allergy 2006; 61: 321-331.
6. Federman DG, Kirsner RS, Moriarty JP, Concato J. The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria. J Am Acad Dermatol 2003; 49(5): 861-864.
7. Dreskin SC, Andrews KY. The thyroid and urticaria. Curr Opin Allergy Clin Immunol 2005; 5: 408-412.
8. Simons FE, Sussman GL, Simons KJ. Effect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1-antagonists hydroxyzine and cetirizine in patients with chronic urticaria. Journal of Allergy and Clinical Immunology 1995; 95(3): 685-693.
9. Wedi B, Novacovic V, Koerner M, Kapp A. Chronic urticaria serum induces histamine release, leukotriene production and basophil CD63 surface expression - inhibitory effects of anti-inflammatory drugs. J Allergy Clin Immunol 2000; 105: 552-560.